Takehiko Sasazuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Takehiko Sasazuki has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Akinori Kimura
Institute of Science Tokyo , Bunkyo-ku, Tokyo 113-8510
3 shared publications - Aiko Sato-Otsubo
Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication Arne Svejgaard
State University Hospital, Copenhagen, Denmark
1 shared publicationBernard Mach
University of Geneva, Geneva, Switzerland
1 shared publication- Bo Dupont
Immunology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center , New York, NY 10021
1 shared publication - Chaur-Jong Hu
Dementia Center, Shuang Ho Hospital and Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
1 shared publication
Latest Publications
- Open Access
- 4 March 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (9) , eabj9867
Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules
Specific MHC class II alleles are strongly associated with susceptibility to various autoimmune diseases. Although the primary function of MHC class II molecules is to present peptides to helper T cells, MHC class II molecules also function like a chaperone to transport misfolded intracellular proteins to the cell surface. In this study, we found that autoantibodies in patients with Graves’ disease preferentially recognize thyroid-stimulating hormone receptor (TSHR) complexed with MHC class II molecules of Graves’ disease risk alleles, suggesting that the aberrant TSHR transported by MHC class II molecules is the target of autoantibodies produced in Graves’ disease. Mice injected with cells expressing mouse TSHR complexed with MHC class II molecules, but not TSHR alone, produced anti-TSHR autoantibodies. These findings suggested that aberrant self-antigens transported by MHC class II molecules exhibit antigenic properties that differ from normal self-antigens and abrogate self-tolerance, providing a novel mechanism for autoimmunity.
- 4 March 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (9) , eabj9867
Open AccessAbrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules
Specific MHC class II alleles are strongly associated with susceptibility to various autoimmune diseases. Although the primary function of MHC class II molecules is to present peptides to helper T cells, MHC class II molecules also function like a chaperone to transport misfolded intracellular proteins to the cell surface. In this study, we found that autoantibodies in patients with Graves’ disease preferentially recognize thyroid-stimulating hormone receptor (TSHR) complexed with MHC class II molecules of Graves’ disease risk alleles, suggesting that the aberrant TSHR transported by MHC class II molecules is the target of autoantibodies produced in Graves’ disease. Mice injected with cells expressing mouse TSHR complexed with MHC class II molecules, but not TSHR alone, produced anti-TSHR autoantibodies. These findings suggested that aberrant self-antigens transported by MHC class II molecules exhibit antigenic properties that differ from normal self-antigens and abrogate self-tolerance, providing a novel mechanism for autoimmunity.
- Open Access
- 1 March 2016
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (3) , S372-S374
High Risk HLA Allele for Severe Acute Graft-Versus-Host-Disease and Mortality in Unrelated Donor Hematopoietic Stem Cell Transplantation
- 1 March 2016
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (3) , S372-S374
Open AccessHigh Risk HLA Allele for Severe Acute Graft-Versus-Host-Disease and Mortality in Unrelated Donor Hematopoietic Stem Cell Transplantation
- Open Access
- 20 October 2004
- Published by Wiley in Tissue Antigens
- Vol. 64 (5) , 600-607
Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity
Abstract: In order to determine highly immunogenic severe acute respiratory syndrome coronavirus (SARS‐CoV) epitope peptides capable of inducing long‐lasting immunity, we first screened immunoglobulin‐G (IgG) antibodies reactive to 197 different overlapping 15‐mers from the SARS‐CoV proteins in the sera of three infected patients. Forty‐two peptides among them were reactive to the sera from all three patients. Consequently, we tested for the reactivity of these 42 peptides to patients' sera (n = 45) at 6‐month post‐infection. The significantly higher levels of IgG antibodies specific to three (S791, M207 and N161) of 42 peptides were detectable in the post‐infection sera from 23 (51%), 27 (60%) and 19 (42%) of 45 patients, respectively. These three peptides, recognized by their long‐lasting immunity, may provide a better understanding of the immunogenicity of SARS‐CoV.
- 20 October 2004
- Published by Wiley in Tissue Antigens
- Vol. 64 (5) , 600-607
Open AccessAssessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity
Abstract: In order to determine highly immunogenic severe acute respiratory syndrome coronavirus (SARS‐CoV) epitope peptides capable of inducing long‐lasting immunity, we first screened immunoglobulin‐G (IgG) antibodies reactive to 197 different overlapping 15‐mers from the SARS‐CoV proteins in the sera of three infected patients. Forty‐two peptides among them were reactive to the sera from all three patients. Consequently, we tested for the reactivity of these 42 peptides to patients' sera (n = 45) at 6‐month post‐infection. The significantly higher levels of IgG antibodies specific to three (S791, M207 and N161) of 42 peptides were detectable in the post‐infection sera from 23 (51%), 27 (60%) and 19 (42%) of 45 patients, respectively. These three peptides, recognized by their long‐lasting immunity, may provide a better understanding of the immunogenicity of SARS‐CoV.
- 1 January 1999
- Published by Wiley in Vox Sanguinis
- Vol. 77 (3) , 164-191
Nomenclature for Factors of the HLA System, 1998
Click on the article title to read more.
- 1 January 1999
- Published by Wiley in Vox Sanguinis
- Vol. 77 (3) , 164-191
Nomenclature for Factors of the HLA System, 1998
Click on the article title to read more.
- Open Access
- 1 November 1998
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 11 (11) , 1027-1032
Molecular dynamics simulations of HLA-DR4 (DRB1*0405) complexed with analogue peptide: conformational changes in the putative T-cell receptor binding regions
The specific recognition of foreign peptide bound to the major histocompatibility complex (MHC) molecule by T-cell receptor (TCR) leads to T-cell activation. We found that analogue peptides containing single amino acid substitutions at the third amino acid position (p3), p5, p7 and p8 of the index peptide (YWALEAAAD) induced different response patterns of T cell clones specific for the index peptide in the context of the human MHC class II molecule HLA-DR4. Analogue peptides were classified into three types, agonists, antagonists or null peptides (non-agonistic and non-antagonistic peptides). A molecular basis for how these slight changes lead to such different consequences for T cells has not been described. To explore the mechanistic basis of these observations, molecular dynamics simulations at 300 K of 300 ps duration were carried out for the DR4-index peptide, DR4-agonist, and DR4-antagonist complexes. The simulations showed that the DR4-antagonist complexes were distinguished from the DR4-index peptide and DR4-agonist complexes by relatively higher deviations of C(alpha) atoms in proposed TCR-binding regions, suggesting that subtle changes of the exposed framework of the peptide binding groove by the antagonist peptides could induce the TCR antagonistic activities.
- 1 November 1998
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 11 (11) , 1027-1032
Open AccessMolecular dynamics simulations of HLA-DR4 (DRB1*0405) complexed with analogue peptide: conformational changes in the putative T-cell receptor binding regions
The specific recognition of foreign peptide bound to the major histocompatibility complex (MHC) molecule by T-cell receptor (TCR) leads to T-cell activation. We found that analogue peptides containing single amino acid substitutions at the third amino acid position (p3), p5, p7 and p8 of the index peptide (YWALEAAAD) induced different response patterns of T cell clones specific for the index peptide in the context of the human MHC class II molecule HLA-DR4. Analogue peptides were classified into three types, agonists, antagonists or null peptides (non-agonistic and non-antagonistic peptides). A molecular basis for how these slight changes lead to such different consequences for T cells has not been described. To explore the mechanistic basis of these observations, molecular dynamics simulations at 300 K of 300 ps duration were carried out for the DR4-index peptide, DR4-agonist, and DR4-antagonist complexes. The simulations showed that the DR4-antagonist complexes were distinguished from the DR4-index peptide and DR4-agonist complexes by relatively higher deviations of C(alpha) atoms in proposed TCR-binding regions, suggesting that subtle changes of the exposed framework of the peptide binding groove by the antagonist peptides could induce the TCR antagonistic activities.
- 1 August 1996
- Published by Wiley in Acta Paediatrica
- Vol. 85 (8) , 916-918
HLA DP antigens and post‐streptococcal acute glomerulonephrius
We have typed 58 Japanese patients with post‐streptococcal acute glomerulonephritis (PSAGN) for HLA DRB1, DQA1, DQB1, DPA1 and DPB1 genes by the HLA‐DNA typing method using a polymerase chain reaction (PCR)‐sequence specific oligonucleotide probe (SSOP) technique. The control subjects were 317 healthy unrelated individuals. Frequencies of HLA DPA 1*02022 and DPB 1*0501, which are in linkage disequilibrium and encode HLA‐DP5 antigen, were significantly increased in patients with PSAGN than those in control (pc < 0.0005 and pc < 0.005, respectively). Frequencies of HLA DPA1*01 and DPA1*0201 were significantly decreased in patients when compared with controls (pC < 0.05, for both). No significant difference in allele frequencies between the two groups was observed in the DRB1, DQA1 and DQB1 genes. This is the first report documenting the association of HLA‐DP alleles with PSAGN. We speculate that H LA‐ DP5 antigens may be involved in the development of PSAGN.
- 1 August 1996
- Published by Wiley in Acta Paediatrica
- Vol. 85 (8) , 916-918
HLA DP antigens and post‐streptococcal acute glomerulonephrius
We have typed 58 Japanese patients with post‐streptococcal acute glomerulonephritis (PSAGN) for HLA DRB1, DQA1, DQB1, DPA1 and DPB1 genes by the HLA‐DNA typing method using a polymerase chain reaction (PCR)‐sequence specific oligonucleotide probe (SSOP) technique. The control subjects were 317 healthy unrelated individuals. Frequencies of HLA DPA 1*02022 and DPB 1*0501, which are in linkage disequilibrium and encode HLA‐DP5 antigen, were significantly increased in patients with PSAGN than those in control (pc < 0.0005 and pc < 0.005, respectively). Frequencies of HLA DPA1*01 and DPA1*0201 were significantly decreased in patients when compared with controls (pC < 0.05, for both). No significant difference in allele frequencies between the two groups was observed in the DRB1, DQA1 and DQB1 genes. This is the first report documenting the association of HLA‐DP alleles with PSAGN. We speculate that H LA‐ DP5 antigens may be involved in the development of PSAGN.
- 1 August 1992
- Published by Springer Nature in Immunogenetics
- Vol. 36 (5) , 319-325
Allele-specific expression of the cytoplasmic exon of HLA-DQB1 gene
The β chain of the HLA-DQ molecule is shorter by eight amino acid residues than other major histocompatibility complex class II β chains due to elimination of the fifth exon coding for part of the cytoplasmic domain. This elimination is caused by one base substitution in the splice accepter site of the exon. We found that two HLA-DQB1 alleles, DQB1 * 0503 and DQB1 * 0601, did not have this substitution, and the exon was utilized in these two alleles. However, two forms of HLA-DQB mRNA, with or without exon 5, were generated in Epstein-Barr virus-transformed cell lines homozygous for DQB1 * 0503 or DQB1*0601, indicating alternative mRNA splicing. The alternative splicing of DQB1*0601 mRNA was also found in peripheral blood lymphocytes and L cell transfectants. To investigate the functional relevance of the allele-specific long cytoplasmic tail of HLA-DQ β chain, we developed three types of L cell transfectants expressing exclusively the HLA-DQw6 molecules with short cytoplasmic tail, long cytoplasmic tail, or both forms of the β chain, and used them as antigen presenting cells for streptococcal cell wall antigen-specific T cell lines. These three types of transfectants could function almost equally well as antigen presenting cells. It was thus demonstrated that both forms of HLA-DQ β chain, with or without eight amino acid residues coded for by the exon 5, can be associated with the HLA-DQ α chain, be expressed on the cell surface, and function as restriction molecules in antigen recognition by the CD4+ T cells.
- 1 August 1992
- Published by Springer Nature in Immunogenetics
- Vol. 36 (5) , 319-325
Allele-specific expression of the cytoplasmic exon of HLA-DQB1 gene
The β chain of the HLA-DQ molecule is shorter by eight amino acid residues than other major histocompatibility complex class II β chains due to elimination of the fifth exon coding for part of the cytoplasmic domain. This elimination is caused by one base substitution in the splice accepter site of the exon. We found that two HLA-DQB1 alleles, DQB1 * 0503 and DQB1 * 0601, did not have this substitution, and the exon was utilized in these two alleles. However, two forms of HLA-DQB mRNA, with or without exon 5, were generated in Epstein-Barr virus-transformed cell lines homozygous for DQB1 * 0503 or DQB1*0601, indicating alternative mRNA splicing. The alternative splicing of DQB1*0601 mRNA was also found in peripheral blood lymphocytes and L cell transfectants. To investigate the functional relevance of the allele-specific long cytoplasmic tail of HLA-DQ β chain, we developed three types of L cell transfectants expressing exclusively the HLA-DQw6 molecules with short cytoplasmic tail, long cytoplasmic tail, or both forms of the β chain, and used them as antigen presenting cells for streptococcal cell wall antigen-specific T cell lines. These three types of transfectants could function almost equally well as antigen presenting cells. It was thus demonstrated that both forms of HLA-DQ β chain, with or without eight amino acid residues coded for by the exon 5, can be associated with the HLA-DQ α chain, be expressed on the cell surface, and function as restriction molecules in antigen recognition by the CD4+ T cells.
- 1 June 1992
- Published by Springer Nature in Immunogenetics
- Vol. 36 (2) , 130-133
Sequence analysis of three novel DRw14-DRB1 alleles
- 1 June 1992
- Published by Springer Nature in Immunogenetics
- Vol. 36 (2) , 130-133
Sequence analysis of three novel DRw14-DRB1 alleles